The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic

Maria A O'Connell1, John D Hayes2

  • 1School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, U.K. m.oconnell@uea.ac.uk.

Insights

Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) is a key regulator of cellular antioxidant responses. Its complex regulation and therapeutic potential in various diseases are increasingly recognized, making it a significant drug target.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Biochemistry

Background:

  • Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) is a master regulator of the antioxidant response.
  • Its role in physiological and pathological processes like redox signaling, metabolism, and aging is widely acknowledged.
  • Nrf2 is implicated in cellular adaptation to stress, drug metabolism, inflammation, and neurodegeneration.

Purpose of the Study:

  • To highlight the complex regulatory mechanisms of Nrf2.
  • To underscore the growing therapeutic interest in Nrf2 modulation for various diseases.
  • To review the cross-talk of Nrf2 with other signaling pathways.

Main Methods:

  • Literature review focusing on Nrf2 regulation and function.
  • Analysis of Nrf2's interaction with key signaling pathways like Keap1, GSK-3/β-TrCP, and NF-κB.
  • Examination of Nrf2's role in disease pathogenesis and therapeutic strategies.

Main Results:

  • Nrf2 regulation involves intricate cross-talk with multiple signaling pathways beyond Keap1.
  • Pathways such as GSK-3/β-TrCP, Hrd1, NF-κB, Notch, and AMP kinase influence Nrf2 activity.
  • Nrf2's involvement spans diverse processes including chemoprevention, chemoresistance, toxicity, and aging.

Conclusions:

  • Nrf2 is a crucial target for therapeutic intervention due to its beneficial roles in disease.
  • Modulating the Nrf2 pathway holds promise for treating conditions related to oxidative stress and inflammation.
  • Ongoing research focuses on developing novel small molecules to target the Nrf2 pathway in clinical trials.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

2.5K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K